SEC Form D filing

Consano Bio, Inc., 2025-12-12

An SEC Form D private-offering notice from Burlington, MA, a $16,840,000 filer-stated offering target in Biotech. Filed 2025-12-12. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Consano Bio, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing non opioid therapeutics for chronic orthopedic pain conditions, lead candidate C-1101 for chronic sciatica

Filed 2025-12-12Filed to raise $16,840,000First money in 2024-10-15Raised so far $16,840,000HQ (as filed) Burlington, MASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified consanobio.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source